Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 7-jild 6-son (2022)
THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF DIABETIC RETINOPATHY (LITERATURE REVIEW)
NORMATOVA Nargiza Mirshovkatovna, ХАМИДУЛЛАЕВ Фирдавс Фаридович, САИДОВ Темур Толибович
Annotatsiya
The article discusses the treatment with the use of angiogenesis inhibitors in the complex treatment of diabetic macular edema. A comparative analysis of all types of anti-VGEF drugs for macular edema is given. The use of brolucizumab is described in detail as the most optimal method among anti-VGEF drugs for the elimination of macular edema. It also provides the latest data with clinically validated data on the use of this drug.
ингибиторы ангиогенеза, VGEF, сахарный диабет, диабетическая ретинопатия,макулярный отекangiogenesis inhibitors, VGEF, diabetes mellitus, diabetic retinopathy, macular edemaangiogenez ingibitorlari, VGEF, qandli diabet, diabetik retinopatiya ,makulyar shish
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.